These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18021307)

  • 1. Open-label trials and drug registration: a European regulator's view.
    Casteels M; Flamion B
    J Thromb Haemost; 2008 Feb; 6(2):232-4. PubMed ID: 18021307
    [No Abstract]   [Full Text] [Related]  

  • 2. Double-blind studies are not always optimum for evaluation of a novel therapy: the case of new anticoagulants.
    Büller HR; Halperin JL; Bounameaux H; Prins M
    J Thromb Haemost; 2008 Feb; 6(2):227-9. PubMed ID: 18034770
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of cardioembolic stroke].
    Gil Núñez A
    Neurologia; 2012 Mar; 27 Suppl 1():15-26. PubMed ID: 22682206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The X-VeRT study].
    Colonna P; Troccoli R; Botto GL
    G Ital Cardiol (Rome); 2015 Jun; 16(6):325-8; discussion 328-30. PubMed ID: 26156692
    [No Abstract]   [Full Text] [Related]  

  • 5. Clopidogrel as antithrombotic therapy in atrial fibrillation.
    Veloso HH; de Paola AA
    Chest; 2005 Jul; 128(1):475; author reply 475. PubMed ID: 16002984
    [No Abstract]   [Full Text] [Related]  

  • 6. Is it time to abandon complete blinded independent central radiological evaluation of progression in registration trials?
    Pignatti F; Hemmings R; Jonsson B
    Eur J Cancer; 2011 Aug; 47(12):1759-62. PubMed ID: 21641204
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical studies with anticoagulants to improve survival in cancer patients.
    Gerotziafas GT; Papageorgiou C; Hatmi M; Samama MM; Elalamy I
    Pathophysiol Haemost Thromb; 2008; 36(3-4):204-11. PubMed ID: 19176993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How well does blinding work in randomized controlled trials?: a counterpoint.
    Boehmer J; Yong P
    Clin Pharmacol Ther; 2009 May; 85(5):463-5. PubMed ID: 19381149
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antithrombotic therapy in patients with atrial fibrillation: a comment on the European guidelines].
    Said SM; Nahrendorf W; Schmidt H; Braun-Dullaeus RC
    Dtsch Med Wochenschr; 2011 Jun; 136(25-26):1384-5. PubMed ID: 21674428
    [No Abstract]   [Full Text] [Related]  

  • 10. Chest physicians issue guidelines on antithrombotic therapy.
    Thompson CA
    Am J Health Syst Pharm; 2008 Aug; 65(16):1490-2. PubMed ID: 18693194
    [No Abstract]   [Full Text] [Related]  

  • 11. [Limitations of anticoagulant therapy].
    Martí-Fàbregas J; Delgado-Mederos R; Mateo J
    Neurologia; 2012 Mar; 27 Suppl 1():27-32. PubMed ID: 22682207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early lytic treatment of massive pulmonary embolism.
    Cardiovasc J S Afr; 2002; 13(4):218-9. PubMed ID: 12402933
    [No Abstract]   [Full Text] [Related]  

  • 13. Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis.
    Naci H; Davis C; Savović J; Higgins JPT; Sterne JAC; Gyawali B; Romo-Sandoval X; Handley N; Booth CM
    BMJ; 2019 Sep; 366():l5221. PubMed ID: 31533922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trials.
    Hacke W; Lyden P; Emberson J; Baigent C; Blackwell L; Albers G; Bluhmki E; Brott T; Cohen G; Davis SM; Donnan GA; Grotta JC; Howard G; Kaste M; Koga M; von Kummer R; Lansberg MG; Lindley RI; Olivot JM; Parsons M; Sandercock PA; Toni D; Toyoda K; Wahlgren N; Wardlaw JM; Whiteley WN; Del Zoppo G; Lees KR;
    Int J Stroke; 2018 Feb; 13(2):175-189. PubMed ID: 29171359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of oral anticoagulants in complex clinical situations with atrial fibrillation.
    Gullón A; Sánchez Fuentes D; López-de-Sá E; Martí-Almor J; Barón-Esquivias G; Jiménez López J; Del Mar Contreras Muruaga M; Suárez Fernández C
    Med Clin (Barc); 2018 Jun; 150 Suppl 1():8-24. PubMed ID: 30502871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Life after DIAS II.
    Donnan GA; Davis SM
    Int J Stroke; 2007 Nov; 2(4):236-7. PubMed ID: 18705921
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study.
    Sarode R; Milling TJ; Refaai MA; Mangione A; Schneider A; Durn BL; Goldstein JN
    Circulation; 2013 Sep; 128(11):1234-43. PubMed ID: 23935011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical aspects of the TNK-S2B trial of tenecteplase versus alteplase in acute ischemic stroke: an efficient, dose-adaptive, seamless phase II/III design.
    Levin B; Thompson JL; Chakraborty B; Levy G; MacArthur R; Haley EC
    Clin Trials; 2011 Aug; 8(4):398-407. PubMed ID: 21737464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e302-4. PubMed ID: 15173052
    [No Abstract]   [Full Text] [Related]  

  • 20. Registry of clinical trials of antithrombotic drugs in cancer. The Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Subcommittee on Hemostasis and Malignancy.
    Zacharski LR; Donati MB
    Thromb Haemost; 1989 Jun; 61(3):526-8. PubMed ID: 2799765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.